Mahendraratnam, Nirosha
Farley, Joel F.
Basch, Ethan
Proctor, Amber
Wheeler, Stephanie B.
Dusetzina, Stacie B.
Article History
Received: 9 October 2018
Accepted: 5 March 2019
First Online: 26 March 2019
Compliance with ethical standards
:
: Dr. Mahendraratnam was a Worldwide Health Economics and Outcomes Research Pre-doctoral Fellow at Bristol-Myers Squibb and a Fellow at the Duke-Margolis Center for Health Policy. She completed an internship a Genentech, a member of the Roche Group in 2015. Dr. Wheeler received served as the Primary Investigator for a project funded by Pfizer, but it is unrelated to this work. Dr. Dusetzina is a member of the Institute for Clinical and Economic Review (ICER) Midwest Comparative Effectiveness Public Advisory Council and served on the National Academy of Sciences, Engineering, and Medicine Committee “Ensuring Patient Access to Affordable Drug Therapies.” All the other authors declare that they have no conflicts of interest.